Press Releases

Press Releases

    Date Title View
    09/23/21
    Summary ToggleHorizon Therapeutics plc Announces Agenda for Virtual R&D Day for Investors and Analysts on Sept. 29, 2021
    PDF Version
    09/23/21
    Summary ToggleHorizon Therapeutics plc Announces Data Showing UPLIZNA® (inebilizumab-cdon) Also Produces Rapid and Sustained B-Cell Depletion in African Americans with Neuromyelitis Optica Spectrum Disorder (NMOSD)
    PDF Version
    09/21/21
    Summary ToggleHorizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis
    PDF Version
    09/16/21
    Summary ToggleHorizon Therapeutics plc Named One of the 2021 Best Workplaces for Women™ by Fortune and Great Place to Work®
    PDF Version
    09/07/21
    Summary ToggleHorizon Therapeutics plc Initiates Randomized Controlled Clinical Trial Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Chronic (Inactive) Thyroid Eye Disease (TED)
    PDF Version
    09/01/21
    Summary ToggleHorizon Therapeutics plc Named One of PEOPLE’s 100 Companies That Care®
    PDF Version
    08/23/21
    Summary ToggleHorizon Therapeutics plc to Participate in Upcoming Conferences
    PDF Version
    08/04/21
    Summary ToggleHorizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance
    07/16/21
    Summary ToggleFortune Names Horizon Therapeutics One of the 2021 Best Workplaces for Millennials™
    PDF Version
    07/08/21
    Summary ToggleHorizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021
    PDF Version
    Displaying 11 - 20 of 608 results